Science Explorer Interactive view Map
Company · Tokyo · Japan

LTT Bio-Pharma (Japan)

ltt.co.jp/englishROR OpenAlex
Research works
105
▲ 202% vs 2013–17
Citations
2.1k
19.6 per fractional work
Top-10% rate
12.0%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: LTT Bio-Pharma (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.83× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.96× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 4.39× its world share, 1 worksImmunology and Micro…Neuroscience: 0.53× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.41× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.23× its world share, 0 worksChemistryComputer Science: 0.13× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 2.84× its world share, 1 worksEarth and Planetary …Engineering: 0.66× its world share, 1 worksEngineeringEnvironmental Science: 0.32× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.64× its world share, 0 worksMaterials ScienceHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 2.28× its world share, 6 worksMedicineVeterinary: 6.34× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.4×. Every wedge is a field page.

Which keywords describe research at LTT Bio-Pharma (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Antimicrobial Resistance, Hemostasis, Nuclear Receptors, Antibiotic Pharmacokinetics, Critically Ill Patients, Metabolic Regulation and Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation10▲ 4.0×29 topics
  2. Antimicrobial Resistance6▲ 24×5 topics
  3. Oxidative Stress6▲ 2.9×20 topics
  4. Cancer6▲ 3.7×16 topics
  5. Epidemiology5▲ 1.18×20 topics
  6. Hemostasis4▲ 28×4 topics
  7. Nuclear Receptors4▲ 23×5 topics
  8. Antibiotic Pharmacokinetics4▲ 92×1 topic
  9. Critically Ill Patients4▲ 92×1 topic
  10. Metabolic Regulation4▲ 13×3 topics
  11. ATP-dependent Transporters4▲ 68×1 topic
  12. Clinical Trials4▲ 5.6×6 topics
  13. Multidrug Resistance4▲ 58×1 topic
  14. Synaptic Plasticity3▲ 9.9×4 topics
  15. Bone Health3▲ 26×3 topics
  16. Depression3▲ 3.3×9 topics
  17. Neurological Disorders3▲ 3.7×4 topics
  18. Antioxidant Activity2▲ 4.3×8 topics
  19. Teratogenicity2▲ 35×2 topics
  20. Cognitive Function2▲ 12×3 topics
  21. Antibiotic Resistance2▲ 5.5×4 topics
  22. Global Burden2▲ 4.1×6 topics
  23. Pharmacology2▲ 6.7×6 topics
  24. Dendritic Spines2▲ 13×2 topics
  25. Pregnancy2▲ 9.2×2 topics
  26. Antiepileptic Drugs2▲ 20×2 topics
  27. Drug Development2▲ 14×3 topics
  28. GABAergic2▲ 15×1 topic
  29. Neuronal Circuits2▲ 11×2 topics
  30. Neurotransmission2▲ 15×1 topic
  31. Genetic Variation2▲ 6.1×4 topics
  32. Neurodevelopmental Disorders2▲ 12×2 topics
  33. Glycosylation2▲ 8.4×3 topics
  34. Pharmacokinetics2▲ 6.4×4 topics
  35. Malformations2▲ 39×1 topic
  36. Prenatal Exposure2▲ 39×1 topic
  37. Thrombosis2▲ 7.9×4 topics
  38. Adverse Drug Reactions2▲ 24×2 topics
  39. Cytochrome P4502▲ 23×2 topics
  40. Hemodynamics2▲ 23×2 topics

Which research topics does LTT Bio-Pharma (Japan) publish most on?

By volume in 2022–2025: Advanced biosensing and bioanalysis techniques, Geological and Tectonic Studies in Latin America, Asthma and respiratory diseases and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.

Advanced biosensing and …0Advanced biosensing and bioanalysis techniques: 0 fractional worksGeological and Tectonic …0Geological and Tectonic Studies in Latin America: 0 fractional worksAsthma and respiratory diseases: 0 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional worksPharmacy and Medical Practices: 0 fractional worksHormonal and reproductive studies: 0 fractional worksCardiac electrophysiology and arrhythmias: 0 fractional worksInflammatory mediators a…0Inflammatory mediators and NSAID effects: 0 fractional worksMedical research and treatments: 0 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 0 fractional works
Molecular BiologyGeophysicsPhysiologyPulmonary and Respiratory Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  2. 2 Geological and Tectonic Studies in Latin America Geophysics 0 works
  3. 3 Asthma and respiratory diseases Physiology 0 works
  4. 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  5. 5 Pharmacy and Medical Practices Pharmacology 0 works
  6. 6 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  8. 8 Inflammatory mediators and NSAID effects Pharmacology 0 works
  9. 9 Medical research and treatments Surgery 0 works
  10. 10 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.8%not open50.2%

World: 28% of research is openly available.

with international co-authors17.9%domestic only82.1%

World: 19% is written across borders.

How has LTT Bio-Pharma (Japan)'s research output changed?

Output in 2018–2022 was 202% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.